2Volker NA, Hehenkamp WJ, Smit P, et a/.Economic evalu- ation of uterine artery embolization versus hysterctomy in the treatment of symptomatic uterine fibroids:results from the randomized EMMY trial [J].J Vasc Interven Radiol, 2006,19(7) : 1007-1016. 被引量：1
3Markowski DN, Bartnitzke S, L ning T.MED 12 mutations in uterinefibroids-their relationship to cytogenetic sub- groups[J].Int J Cancer, 2012,131 (7) : 1528-1536. 被引量：1
4Mkinen N, Vahteristo P, Btitzow R,et a/.Exomie landscape of MED12 mutation-negative and -positive uterine leiomy- oma[J].Int J Cancer, 2014,133(4) : 1008-1012. 被引量：1
5Shaik NA, Lone WG, Khan IA.Deteetion of somatic muta- tions and germline polymorphismsin mitochondrial DNA of uterine fibroids patients [J].Genet Test Mol Biomarker, 2011,15(7/8) :537-541. 被引量：1
7Dorenberg E J, Hol PK, Jakobsen JA,et a/.Improved infarc- tionrates in fibroids after the introduction of contrast- enhanced ultrasound during uterine artery embolization[J]. Acta Radiologica, 2012,53 ( 1 ) : 34-38. 被引量：1
8Drazancic A.Antenatal care in developed countries--what should be done?[J].J Perinat Med, 2001,29 (3) : 188-192. 被引量：1
9Bozzini N,Rodrigues CJ,Petti DA,et a/. Effects of treat- ment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure [J].Acta Obstet Gynecol Scand, 2003,82(4) : 330-334. 被引量：1
10Scialli AR,Jestila KJ. Sustained benefits of leuprolide ac- etate with or without subsequent medroxyprogesterone ac- etate in the nonsurgical management of leiomyomata u- teri[J].Fertil Steril, 1995,64(2) : 313-320. 被引量：1
